A Randomized Trial Comparing Tamoxifen Therapy vs. Tamoxifen Prophylaxis in Bicalutamide-Induced Gynecomastia

Boccardo, 2000, Hormone therapy of prostate cancer: is there a role for antiandrogen monotherapy?, Crit Rev Oncol/Hematol, 35, 121, 10.1016/S1040-8428(00)00051-2 Iversen, 2000, Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup, J Urol, 164, 1579, 10.1016/S0022-5347(05)67032-2 McLeod, 2006, Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer, BJU Int, 97, 247, 10.1111/j.1464-410X.2005.06051.x Iversen, 1999, Quality of life issues relating to endocrine treatment options, Eur Urol, 36, 20, 10.1159/000052339 Di Lorenzo, 2005, Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy, J Urol, 174, 2197, 10.1097/01.ju.0000181824.28382.5c Eaton, 2004, Once weekly tamoxifen in the prevention of gynaecomastia and breast pain secondary to bicalutamide therapy, J Urol, 171, 282, 10.1016/S0022-5347(18)38306-X Boccardo, 2005, Evaluation of tamoxifen and anastrozole in the prevention of gynaecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer, J Clin Oncol, 23, 808, 10.1200/JCO.2005.12.013 Saltzstein, 2005, Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole, Prostate Cancer Prostatic Dis, 8, 75, 10.1038/sj.pcan.4500782 Perdonà, 2005, Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial, Lancet Oncol, 6, 295, 10.1016/S1470-2045(05)70103-0 See, 2003, Immediate treatment with bicalutamide 150 mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostatic cancer, Eur Urol, 44, 512, 10.1016/S0302-2838(03)00366-X Van Poppel, 2005, Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer, Eur Urol, 47, 587, 10.1016/j.eururo.2004.12.003 Dobs, 2005, Incidence and management of gynecomastia in men treated for prostate cancer, J Urol, 174, 1737, 10.1097/01.ju.0000176461.75794.f8 Van Poppel, 2005, Development and validation of a new questionnaire to assess gynaecomastia and breast pain in patients receiving bicalutamide, Eur Urol, 4, 80, 10.1016/S1569-9056(05)80320-3 Fradet, 2007, Eur Urol, 52, 106, 10.1016/j.eururo.2007.01.031 Bedognetti, 2010, An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients, Eur Urol, 57, 238, 10.1016/j.eururo.2009.05.019 Anelli, 1994, Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients, Cancer, 74, 74, 10.1002/1097-0142(19940701)74:1<74::AID-CNCR2820740113>3.0.CO;2-# Di Lorenzo, 2007, Bicalutamide-induced gynaecomastia: do we have the answer?, Eur Urol, 52, 5, 10.1016/j.eururo.2007.01.063